BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 33510477)

  • 21. Novel DNA methylation loci and genes showing pleiotropic association with Alzheimer's dementia: a network Mendelian randomization analysis.
    Liu D; Wang Y; Jing H; Meng Q; Yang J
    Epigenetics; 2022; 17(7):746-758. PubMed ID: 34461811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nominating novel proteins for anxiety via integrating human brain proteomes and genome-wide association study.
    Jin X; Dong S; Yang Y; Bao G; Ma H
    J Affect Disord; 2024 Aug; 358():129-137. PubMed ID: 38697224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.
    Martiskainen H; Helisalmi S; Viswanathan J; Kurki M; Hall A; Herukka SK; Sarajärvi T; Natunen T; Kurkinen KM; Huovinen J; Mäkinen P; Laitinen M; Koivisto AM; Mattila KM; Lehtimäki T; Remes AM; Leinonen V; Haapasalo A; Soininen H; Hiltunen M
    J Alzheimers Dis; 2015; 43(2):565-73. PubMed ID: 25096612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk.
    Rao S; Ghani M; Guo Z; Deming Y; Wang K; Sims R; Mao C; Yao Y; Cruchaga C; Stephan DA; Rogaeva E
    Neurobiol Aging; 2018 Jun; 66():178.e1-178.e8. PubMed ID: 29395286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.
    Desikan RS; Schork AJ; Wang Y; Witoelar A; Sharma M; McEvoy LK; Holland D; Brewer JB; Chen CH; Thompson WK; Harold D; Williams J; Owen MJ; O'Donovan MC; Pericak-Vance MA; Mayeux R; Haines JL; Farrer LA; Schellenberg GD; Heutink P; Singleton AB; Brice A; Wood NW; Hardy J; Martinez M; Choi SH; DeStefano A; Ikram MA; Bis JC; Smith A; Fitzpatrick AL; Launer L; van Duijn C; Seshadri S; Ulstein ID; Aarsland D; Fladby T; Djurovic S; Hyman BT; Snaedal J; Stefansson H; Stefansson K; Gasser T; Andreassen OA; Dale AM;
    Mol Psychiatry; 2015 Dec; 20(12):1588-95. PubMed ID: 25687773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel proteins for lacunar stroke by integrating genome-wide association data and human brain proteomes.
    Zhang C; Qin F; Li X; Du X; Li T
    BMC Med; 2022 Jun; 20(1):211. PubMed ID: 35733147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Power and pitfalls of the genome-wide association study approach to identify genes for Alzheimer's disease.
    Sherva R; Farrer LA
    Curr Psychiatry Rep; 2011 Apr; 13(2):138-46. PubMed ID: 21312009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Alzheimer's disease GWAS loci with MRI markers of brain aging.
    Chauhan G; Adams HHH; Bis JC; Weinstein G; Yu L; Töglhofer AM; Smith AV; van der Lee SJ; Gottesman RF; Thomson R; Wang J; Yang Q; Niessen WJ; Lopez OL; Becker JT; Phan TG; Beare RJ; Arfanakis K; Fleischman D; Vernooij MW; Mazoyer B; Schmidt H; Srikanth V; Knopman DS; Jack CR; Amouyel P; Hofman A; DeCarli C; Tzourio C; van Duijn CM; Bennett DA; Schmidt R; Longstreth WT; Mosley TH; Fornage M; Launer LJ; Seshadri S; Ikram MA; Debette S
    Neurobiol Aging; 2015 Apr; 36(4):1765.e7-1765.e16. PubMed ID: 25670335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating Genome-Wide Association Study and Brain Expression Data Highlights Cell Adhesion Molecules and Purine Metabolism in Alzheimer's Disease.
    Xiang Z; Xu M; Liao M; Jiang Y; Jiang Q; Feng R; Zhang L; Ma G; Wang G; Chen Z; Zhao B; Sun T; Li K; Liu G
    Mol Neurobiol; 2015 Aug; 52(1):514-21. PubMed ID: 25204495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative analysis of summary data from GWAS and eQTL studies implicates genes differentially expressed in Alzheimer's disease.
    Lee B; Yao X; Shen L;
    BMC Genomics; 2022 Jun; 23(Suppl 4):414. PubMed ID: 35655140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep post-GWAS analysis identifies potential risk genes and risk variants for Alzheimer's disease, providing new insights into its disease mechanisms.
    Wang Z; Zhang Q; Lin JR; Jabalameli MR; Mitra J; Nguyen N; Zhang ZD
    Sci Rep; 2021 Oct; 11(1):20511. PubMed ID: 34654853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's Disease rs117896735 Variant Regulates INPP5F Expression in Brain Tissues and Increases Risk of Alzheimer's Disease.
    Xue F; Gao L; Chen T; Chen H; Zhang H; Wang T; Han Z; Gao S; Wang L; Hu Y; Tang J; Huang L; Liu G; Zhang Y
    J Alzheimers Dis; 2022; 89(1):67-77. PubMed ID: 35848021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common and Rare Genetic Variants Associated With Alzheimer's Disease.
    Marei HE; Althani A; Suhonen J; El Zowalaty ME; Albanna MA; Cenciarelli C; Wang T; Caceci T
    J Cell Physiol; 2016 Jul; 231(7):1432-7. PubMed ID: 26496533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.
    Baird DA; Liu JZ; Zheng J; Sieberts SK; Perumal T; Elsworth B; Richardson TG; Chen CY; Carrasquillo MM; Allen M; Reddy JS; De Jager PL; Ertekin-Taner N; Mangravite LM; Logsdon B; Estrada K; Haycock PC; Hemani G; Runz H; Smith GD; Gaunt TR;
    PLoS Genet; 2021 Jan; 17(1):e1009224. PubMed ID: 33417599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ICA1L Is Associated with Small Vessel Disease: A Proteome-Wide Association Study in Small Vessel Stroke and Intracerebral Haemorrhage.
    Cullell N; Gallego-Fábrega C; Cárcel-Márquez J; Muiño E; Llucià-Carol L; Lledós M; Martín-Campos JM; Molina J; Casas L; Almeria M; Fernández-Cadenas I; Krupinski J
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.
    Hao K; Di Narzo AF; Ho L; Luo W; Li S; Chen R; Li T; Dubner L; Pasinetti GM
    Mol Aspects Med; 2015; 43-44():66-76. PubMed ID: 26116273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hidden risk genes with high-order intragenic epistasis in Alzheimer's disease.
    Sun J; Song F; Wang J; Han G; Bai Z; Xie B; Feng X; Jia J; Duan Y; Lei H
    J Alzheimers Dis; 2014; 41(4):1039-56. PubMed ID: 24762948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic insights into immune mechanisms of Alzheimer's and Parkinson's disease.
    Nott A; Holtman IR
    Front Immunol; 2023; 14():1168539. PubMed ID: 37359515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Key Long Non-Coding RNAs in the Pathology of Alzheimer's Disease and their Functions Based on Genome-Wide Associations Study, Microarray, and RNA-seq Data.
    Han Z; Xue W; Tao L; Zhu F
    J Alzheimers Dis; 2019; 68(1):339-355. PubMed ID: 30776002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship.
    Li QS; Tian C; ; Hinds D; Seabrook GR
    PLoS One; 2020; 15(11):e0241552. PubMed ID: 33152005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.